Epidemiology Practice Questions

Q: A researcher wanted to prove the relation between COPD and smoking. He collected patients records from government hospitals and records of cigarette sales from the finance and taxation department. This is an example of which study design:

Ecological study. ***Ecological study*** - This study design involves analyzing data at a **population level**, rather than individual patient data. The researcher used aggregated data from hospital records (COPD prevalence) and cigarette sales (smoking rates) for populations or groups, not individual patients. - It examines the relationship between an exposure (smoking) and an outcome (COPD) by comparing disease frequencies in different populations with varying levels of exposure. *Cross-sectional* - A cross-sectional study measures the **prevalence** of a disease and exposure at a **single point in time** in individuals. - It does not involve comparing population-level aggregates or using secondary data from different sources to establish associations between population groups. *Posological study* - A posological study focuses on the **dosage** and administration of drugs, often to determine optimal therapeutic regimens. - This term is irrelevant to the described research design, which is concerned with the relationship between smoking and COPD. *Operations research* - Operations research is a discipline that applies analytical methods to improve **decision-making and efficiency** within organizations or systems. - This field is primarily concerned with optimizing processes and resource allocation, not establishing epidemiological associations between risk factors and diseases.

Q: The difference between the incidence in the exposed and non-exposed group is best given by:

Attributable risk. ***Attributable risk*** - **Attributable risk** (AR), also known as risk difference, directly quantifies the absolute difference in disease incidence between an **exposed group** and an **unexposed group**. - It represents the amount of disease incidence (or risk) in the exposed group that is **directly attributable to the exposure**, assuming a causal relationship. *Population attributable risk* - **Population attributable risk** (PAR) measures the proportion of disease incidence in the **total population** that is attributable to the exposure. - It takes into account both the impact of the exposure and the **prevalence of the exposure** in the population, which is distinct from simply comparing exposed and non-exposed groups. *Odds ratio* - The **odds ratio** (OR) is a measure of association between an exposure and an outcome, representing the **odds of an outcome occurring in the exposed group** compared to the odds of it occurring in the unexposed group. - It does not directly express the difference in incidence but rather the **ratio of odds**, often used in case-control studies. *Relative risk* - **Relative risk** (RR), or risk ratio, is the ratio of the **incidence of an outcome in the exposed group** to the incidence in the unexposed group. - It indicates how many times more likely an exposed group is to develop the outcome compared to an unexposed group, expressing a **ratio rather than a difference**.

Q: Which research method is most appropriate for studying the progression of a disease over time?

Cohort Study. ***Cohort Study*** - A **cohort study** observes a group of individuals over a period of time, allowing researchers to track the **natural progression of a disease** from exposure through onset and various stages. - This design is ideal for investigating the **incidence** of disease and identifying risk factors over time. *Cross sectional study* - A **cross-sectional study** assesses exposure and outcome at a **single point in time**, providing a snapshot. - It cannot establish temporality or observe disease progression, as it does not follow individuals over time. *Randomized Control Trials* - **Randomized controlled trials (RCTs)** are primarily designed to evaluate the **effectiveness of interventions** or treatments by comparing outcomes between an experimental group and a control group. - While they follow participants over time, their main goal is not to study the natural progression of an untreated disease. *Interventional Studies* - **Interventional studies** involve manipulating an exposure or treatment to observe its effect, often to test a hypothesis about a causal relationship. - While they track outcomes over time, their focus is on the impact of the intervention rather than the natural history or progression of a disease without intervention.

Q: Which of the following is not an epidemiological indicator?

None of the options. ***None of the options*** - All listed options—**ABER (Annual Blood Examination Rate)**, **Annual parasite index**, and **Annual falciparum incidence**—are indeed widely recognized and utilized **epidemiological indicators**, particularly in the context of malaria surveillance and control. - As such, there is no option presented that is *not* an epidemiological indicator. *ABER* - **ABER (Annual Blood Examination Rate)** is an epidemiological indicator used to assess the annual number of blood smears examined per 1000 population. - It helps to measure the **intensity of surveillance** and case detection efforts in a given area for diseases like malaria. *Annual parasite index* - The **Annual Parasite Index (API)** is an epidemiological indicator that measures the number of confirmed malaria cases per 1000 population per year. - It is crucial for assessing **malaria endemicity** and the burden of the disease in a specific region. *Annual falciparum incidence* - **Annual falciparum incidence** is an epidemiological indicator specifically tracking the number of *Plasmodium falciparum* malaria cases per 1000 population per year. - This indicator is essential for monitoring the **severity and transmission of the most dangerous form of malaria**.

Q: What is the term used to describe the occurrence of a disease in a susceptible person after they have been in contact with a primary case within the incubation period?

Secondary attack rate. ***Secondary attack rate*** - This term specifically measures the **frequency of new cases** among contacts of primary cases within the incubation period. - It is a key epidemiological measure to assess the **transmissibility** of an infectious agent within a defined population group. - Calculated as: (Number of cases among contacts / Number of susceptible contacts) × 100 *Case fatality rate* - This metric represents the **proportion of deaths** among individuals diagnosed with a specific disease, indicating its severity. - It does not describe the occurrence of disease transmission from a primary case to susceptible contacts. *Primary attack rate* - This refers to the **number of cases occurring among the total population at risk** during the initial period of an outbreak. - It differs from secondary attack rate, which specifically measures transmission from a **known primary case to their contacts**. - Primary attack rate does not distinguish between primary and secondary cases. *Tertiary attack rate* - This term is not a commonly used or recognized epidemiological measure. - While disease transmission can occur beyond secondary contacts, there isn't a standard "tertiary attack rate" used in epidemiological practice.

Q: What is the primary ecological unit of study in epidemiology for understanding disease patterns and public health?

Population. ***Population*** - In public health and epidemiology, a **population** is the fundamental unit for studying disease patterns, incidence, prevalence, and risk factors across groups. - Understanding disease at the population level allows for the development of **prevention strategies**, public health interventions, and policy making that impact many individuals. *Individual patient* - While critical for clinical diagnosis and treatment, the **individual patient** represents a single case and does not provide insights into broader disease patterns or public health trends. - Studying individuals primarily informs **patient management** and understanding disease pathophysiology rather than population-level epidemiology. *Community* - A **community** is a group of people living in the same place or having a particular characteristic in common, which is a broader concept than a population. - While public health interventions often target communities, the underlying data and epidemiological analyses are typically based on defined **populations within** or across communities. *Case study* - A **case study** is an in-depth analysis of a single individual, group, or event, offering rich, detailed information. - While valuable for generating hypotheses or understanding rare conditions, a case study does not provide the **statistical power** or generalizability needed to understand disease patterns across large groups.

Q: Incidence of a disease is 4 per 1000 of population with duration of 2 years. Calculate the prevalence?

8 per 1000. ***8 per 1000*** - Prevalence can be estimated by multiplying the **incidence rate** by the **duration of the disease**. - In this case, 4/1000 (incidence) * 2 years (duration) = **8 per 1000**. *4 per 1000* - This value represents the **incidence** of the disease, which is the rate of new cases, not the total number of existing cases (prevalence). - Prevalence includes both new and existing cases over a specified period. *2 per 1000* - This value is obtained by dividing the incidence by the duration (4/2), which is not the correct formula for calculating prevalence in this context. - Doing so would incorrectly imply a lower disease burden than what is indicated by the incidence and duration. *6 per 1000* - This option is simply the sum of incidence and duration (4+2), which does not represent a valid epidemiological calculation for prevalence. - Prevalence is determined by considering both the rate of new cases and how long individuals typically live with the disease.

Q: What is the primary benefit of screening for diseases?

Early detection of diseases. ***Early detection of diseases*** - This is the **primary benefit** and defining purpose of **screening programs** in public health. - Screening identifies diseases in their **presymptomatic or early stage** when individuals are apparently healthy, allowing for intervention before clinical symptoms appear. - According to epidemiological principles, the goal of screening is to detect disease **earlier than it would be found through routine clinical practice**. - Early detection enables better prognosis through **lead time** and **length time bias** advantages. *Timely treatment of identified conditions* - While treatment is the **ultimate goal** of healthcare, it is not specific to screening—treatment occurs whether disease is found through screening or clinical presentation. - Treatment is the **consequence** of early detection, not the primary benefit of the screening process itself. - The unique value of screening lies in **detection**, not treatment per se. *Providing support for patients after diagnosis* - **Patient support** is an important aspect of healthcare but is not the purpose of screening programs. - This is **post-diagnostic care**, which follows after the screening process has identified cases. *Identifying all potential cases of a disease* - **Screening tests** cannot identify all cases due to inherent limitations in **sensitivity** and **specificity**. - Screening aims to identify a significant proportion of cases in a population, accepting that some will be missed (**false negatives**) and some healthy individuals may test positive (**false positives**).

Question 1

A researcher wanted to prove the relation between COPD and smoking. He collected patients records from government hospitals and records of cigarette sales from the finance and taxation department. This is an example of which study design:

Accepted Answer

Ecological study

Answer

Cross-sectional

Answer

Posological study

Answer

Operations research

Question 2

The difference between the incidence in the exposed and non-exposed group is best given by:

Accepted Answer

Attributable risk

Answer

Population attributable risk

Answer

Odds ratio

Answer

Relative risk

Question 3

Which research method is most appropriate for studying the progression of a disease over time?

Accepted Answer

Cohort Study

Answer

Cross sectional study

Answer

Randomized Control Trials

Answer

Interventional Studies

Question 4

Which of the following is not an epidemiological indicator?

Accepted Answer

None of the options

Answer

ABER

Answer

Annual falciparum incidence

Answer

Annual parasite index

Question 5

What is the term used to describe the occurrence of a disease in a susceptible person after they have been in contact with a primary case within the incubation period?

Accepted Answer

Secondary attack rate

Answer

Case fatality rate

Answer

Primary attack rate

Answer

Tertiary attack rate

Question 6

What is the primary ecological unit of study in epidemiology for understanding disease patterns and public health?

Accepted Answer

Population

Answer

Community

Answer

Individual patient

Answer

Case study

Question 7

Incidence of a disease is 4 per 1000 of population with duration of 2 years. Calculate the prevalence?

Accepted Answer

8 per 1000

Answer

4 per 1000

Answer

2 per 1000

Answer

6 per 1000

Question 8

What is the primary benefit of screening for diseases?

Accepted Answer

Early detection of diseases

Answer

Providing support for patients after diagnosis

Answer

Identifying all potential cases of a disease

Answer

Timely treatment of identified conditions

Question 9

What is exponential growth in the context of population dynamics?

Accepted Answer

Rapid increase in population size where growth rate is proportional to current population.

Answer

Gradual increase in population size.

Answer

Population growth that is restricted by environmental factors.

Answer

No significant change in population size.

Question 10

What is the definition of Population Attributable Risk?

Accepted Answer

The difference between incidence in population and incidence in non-exposed.

Answer

The difference between incidence in population and incidence in exposed.

Answer

The difference between incidence in population and incidence in non-exposed compared with incidence in exposed.

Answer

The difference between incidence in exposed and incidence in non-exposed.

Epidemiology — MCQs

Epidemiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?